Nevertheless, for patients with HF undergoing stem cells transplantation, the most important factor for a positive outcome is the amount of CD34+ cells in patients with ischemic, as well as in non-ischemic, HF [19,20,21]. This evidence concerns the gene CD34 and hydrops fetalis.